Dr Poon Yi Ling Eileen

Oncology fascinates Dr Poon with its never-ending possibilities. Upcoming new therapies and exciting progress made in recent years is a culmination of countless peoples’ efforts, with much to be learnt and discovered.

Her passion is in Adolescent and Young Adult Oncology (AYAO), and she is working towards training specifically in this area. This is a field in its infancy, especially in Asia, combining both the science and art of Oncology and Medicine.

Dr Poon recounts that, “Every single time I care for an AYAO patient, it never fails to humble and remind me why I am doing what I am doing. I hope to continue to learn, question and be an all-rounded oncologist, who is adept at treating patients with up-to-date science that is individualized to each patient.”

She is also keen to become an inspiring clinical educator too who is able to individualize teaching strategies to help each young doctor reach their full potential as she believes everyone learns differently with their own needs. Dr Poon has met wonderful inspiring mentors in her short career, and she recognize the importance of educating our younger doctors in order for not just science to be handed over, but also good doctoring. This is a skillset which she feels is increasingly underrated, especially with all the technology advancement.

Outside Oncology, Dr Poon enjoys spending time with her family and loved ones and she suffers from a serious addiction of wander-lust. She is a self-proclaimed adrenaline junkie and she adores pets, especially dogs!

• NUS MRCP, MMed (Int Med) 2012
• NUS MBBS 2007

• Best Houseman
• Best Medical Officer

• Identifying the different important areas in Adult Youth Oncology and how to build on them
• Adult Youth Oncology and the factors that result in them doing so poorly
• Education Research
• Targeted therapy and how best to combine them with systemic chemotherapy

• Poon EYL, Quek RHH, Ang M, Ng RCH, Hassan NH, Low KW Learning beyond the classroom for Medical Oncology Trainees at National Cancer Centre Singapore (NCCS) APMEC 2018. E-poster presentation session 18. D1103
• W.Goh, E. Poon, A. Chan, N. Somasundaram, J. Chan, R.Quek, M. Farid The Spectrum of Sarcomas in the Adolescent and Young Adult (AYA) Population – A single institution review of 345 patients. CTOS 2017, Poster 088 #2804434
• W.H.W Chew, JY Chan, WL Goh, JHC. Lim, SH Tan, N. Somasundaram, EYL Poon, AST Lim, MH Tan, KC Soo, M Teo, TKY Tay, S. Selvarajan, K Sittampalam, R Quek Tumour histology and primary site but not MDM2 amplification levels are prognostic for clinical outcomes in well differentiated and dedifferentiated liposarcomas. Annals of Oncology (2017) 28 (suppl_10): x149-x152.10.1093/announce/mdx675
• T.E. Woldehaimanot, W.Lin Goh, E Poon, G Fan aKam Tong, P Neo Soek Hui, R Quek, M. Farid, A.Chan Prevalence and types of distress among Adult and Young Adolescent (AYA) newly diagnosed with cancer in Singapore. Annals of Oncology (2016) 27 (suppl_9): ix161-ix162.10.1093/annonc/mdw596
• Choudhury Y, Wei X, Chu YH, Ng LG, Tan HS, Koh V, Thike AA, Poon E, Ng QS, Toh CK, Kanesvaran R, Tan PH, Tan MH A multigene assay identifying distinct prognostic subtypes of clear cell renal cell carcinoma with differential response to tyrosine kinase inhibition. Eur Urol. 2015 Jan;67(1):17-20. doi: 10.1016/j.eururo.2014.06.041. Epub 2014 Jul 10.
• Poon E, Ong SJ, Chuang XE, Lim WT, Mohd Zam NA, Chong TW, Al Jajeh I, Mancer K, Tan MH. 'Prechronous' metastasis in clear cell renal cell carcinoma: a case report. J Med Case Rep. 2011 May 13;5:181. doi: 10.1186/1752-1947-5-181.
• Tan MH, Yang J, Tan HL, Wong CF, Tan PH, Sim HG, Ang P, Toh CK, Tay MH, Poon E, Ooi AS, Teh BT. A unique pair of monozygotic twins with concordant clear cell renal cell carcinoma: a case report. Ann Acad Med Singapore. 2010 Jan;39(1):61-3